Skip to main content

Table 1 The baseline demographics of patients in this study

From: Entecavir plus adefovir rescue therapy for chronic hepatitis B patients after multiple treatment failures in real-life practice

Characteristic

Value

Gender (Male/Female, n/n)

32/13

Age, yr

38.64 ± 5.82

Serum ALT (IU/mL)

134.53 ± 32.61

Serum HBV DNA (log 10 copies/mL)

5.4 ± 1.3

LAM/LdT-resistant mutation, n(%)

23(51.11%)

  rtM204I

7

  rtM204I/V + rtL180M

16

ADV-resistant mutation

18(40.00%)

  rtN236T

8

  rtA181T/V

6

  RtN236T + rtA181T/V

4

LAM + ADV resistance

2(4.44%)

Suboptimal response to ETV

4(8.89%)